Learn The Latest In Gene Editing
Resources to help you learn more about the latest in gene editing technology in various industries. Choose your area of research below.
Residual host cell proteins (HCPs), including lipases, can contribute to polysorbate degradation, creating challenges for therapeutic antibody formulation stability. ...
Demeetra has entered into an agreement with Japan’s RIKEN BioResource Research Center (RIKEN BRC) that broadens academic access to research ...
The new Harbor-IN format helps biopharma developers establish production cell lines using animal-origin-free transposase mRNA from the start, while maintaining ...
Early decisions in CHO host selection, cell line development, and process strategy can shape a biologics program long before ...
CleanCut GS ADCC+ CHO: Afucosylated Antibody Production with Maintained Productivity White Paper by Corey Brizzee, PhD, Director of Gene ...
For biologics developers, selection strategy directly affects cell line development timelines, clone quality, productivity, and long-term manufacturing stability. DHFR/MTX and ...
In this presentation, Demeetra CEO Jack Crawford shares new data from Demeetra’s CleanCut™ CHO platform, including initial results from a next-generation CleanCut variant engineered ...
Published in Biotechnology Progress (Wiley/AICHE) — DOI: 10.1002/btpr.70108 Authors: Tiffany McLamarrah et al. (Sanofi, iBET, Demeetra) Download the paper (PDF): https://aiche.onlinelibrary.wiley.com/doi/pdf/10.1002/btpr.70108 Why this matters ...
Abstract Cas-CLOVER is an emerging high-fidelity genome editing system that enables precise and efficient cell engineering. In this study, we ...
NorthX Biologics and Demeetra announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full ...
Demeetra today announced the renewal of Taiho Pharmaceutical's research license for its piggyBac transposase technology. The full announcement is shown ...
Demeetra AgBio has completed the full integration of Hera BioLabs, expanding Demeetra’s rights to the hyperactive Super piggyBac transposase platform ...
We Enable Scientists To Obtain More With Less Inconvenience
Contact us to learn more about our gene editing technology.